首页> 外国专利> liquid composition for the treatment of pediatric otitis media, pediatric oral suspension, method of treatment for pediatric otitis media in patients under 24 months of age and method of treatment for haemophilus influenzae, and beta-lactamase-producing moraxella catarrhalis in pediatric patients with less than 24 months old

liquid composition for the treatment of pediatric otitis media, pediatric oral suspension, method of treatment for pediatric otitis media in patients under 24 months of age and method of treatment for haemophilus influenzae, and beta-lactamase-producing moraxella catarrhalis in pediatric patients with less than 24 months old

机译：小于16岁的小儿中耳炎的液体组合物，小儿口服混悬液，24个月以下小儿中耳炎的治疗方法和流感嗜血杆菌的治疗方法以及产生β-内酰胺酶的卡他莫拉氏菌24个月大

页面导航

摘要
著录项
相似文献

摘要

Summary liquid composition for the treatment of pediatric otitis media, pediatric oral suspension, method of treatment for pediatric otitis media in patients under 24 months of age and method of treatment for haemophilus influenzae, and beta-lactamase-producing moraxella catarrhalis in pediatric patients less than 24 months of age the invention is directed to a pediatric oral suspension composition containing amoxicillin and potassium clavulanate wherein potassium clavulanate is present in an amount of about 21.5 mg / 5 ml or less, and to a method of treating bacterial infections by providing from about one to about fourteen days of dosage of the composition.

机译：用于治疗小儿中耳炎的液体组合物，小儿口服混悬液，24个月以下患者的小儿中耳炎的治疗方法和流感嗜血杆菌的治疗方法以及小儿患者中产生β-内酰胺酶的卡他莫拉菌的治疗方法24个月大时，本发明涉及一种含有阿莫西林和克拉维酸钾的儿科口服混悬液组合物，其中克拉维酸钾的存在量约为21.5 mg / 5 ml或更少，并且涉及一种通过提供约1mg / ml来治疗细菌感染的方法。至组合物剂量的约十四天。

著录项

公开/公告号BR112014016850A2

专利类型
公开/公告日2017-06-13

原文格式PDF
申请/专利权人 ALEJANDRO HOBERMAN;MICHAEL SPECTOR;
展开▼

申请/专利号BR20141116850
发明设计人 ALEJANDRO HOBERMAN;MICHAEL SPECTOR;
展开▼

申请日2013-01-10
分类号A61K9/08;A61K9/10;A61K31/397;A61K31/407;A61K31/424;A61K31/43;
国家 BR
入库时间 2022-08-21 13:40:27

相似文献

专利
外文文献